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ABSTRACT 
Objective: To present conclusions related to the antibiotic drug consumption in one tertiary healthcare institution in Serbia in a 10-year period 
(2001-2010). 
Methods: It has been analyzed the issue of antibiotics for prevention and treatment of patients hospitalized at the Military Medical Academy 
between 2001 and 2010. Antibiotic consumption was expressed as a number of Defined Daily Doses per 100 bed-days (DDD/100BD). 
Results: Total antibiotic consumption ranged from 49.6 DDD/100BD in 2001 up to 60.4 DDD/100BD in 2005. The leading group of antibiotic was third-
generation cephalosporins which accounted for 15.1 DDD/100BD of its maximum consumption in 2007. Ceftriaxone was the most frequently used.  
Conclusion: Analysis of antibiotic consumption, and multidisciplinary approach, has a crucial importance for further survey of protocols 
compliance concerning the antibiotic consumption in one hospital. 
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The irrational use of antibiotics in hospital settings represents 
public health problem. The aim of the antibiotic consumption 
control is an improvement of the healthcare quality, decrease in the 
treatment costs, and reduction of microorganism resistance. The 
strategy for the antibiotic use should be determined, by guidelines, 
for prevention and treatment of infections on the basis of local 
epidemiological data and resistance to antibiotics [1, 2]. 
The rational use of antibiotics is a very complex problem requiring 
the cooperation of different professionals. Changes in the antibiotic 
usage patterns are implying changes in healthcare workers’ 
behavior and attitude, which is extremely difficult to achieve, but 
possible, if strongly supported by the hospital administration [3]. 
The aim of this study is to highlight the antibiotic consumption at the 
Military Medical Academy (MMA), a 1200-bed tertiary care teaching 
hospital during, a 10-year period (2001-2010).  
According to the recommendation of World Health Organization 
(WHO), the antibiotic consumption is expressed as a number of 
Defined Daily Doses per 100 bed-days (DDD/100BD) [4, 5]. 
Monitoring of drug dispensing-related data was carried out through 
the computer-based support system of the MMA. The data of the 
total bed-days of care in hospital, are obtained from the medical 
statistics in the form of annuals [6].  
The total use of antibiotics, observed over the 10-year investigation 
period, ranged from 49.6 DDD/100BD in 2001 up to 60.4 
DDD/100BD in 2005 (table 1). 
 
Table 1: Total consumption of systemic antibiotics at the MMA during the 2001-2010 period expressed as the number of DDD/100BD 
Year 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 
Antibiotic consumption 49.6 57.0 54.4 58.3 60.4 56.4 56.8 58.2 54.9 59.5 
The most widely used groups of antibiotics, were the other beta-lactam antibiotics, including cephalosporin and Carbapenem with the maximum of 















































Fig. 1: The consumption of antibiotic for systemic use at the MMA during the 2001-2010 periods expressed as the number of DDD/100BD 
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Broad-spectrum penicillins, with the maximum of 6.5 DDD/100BD 
in 2001 were the most commonly used in the penicillin group., 
Third-generation cephalosporins represented the most widely used 
antibiotics, which accounted for 15.1 DDD/100BD of its maximum 










































Fig. 2: The consumption of beta-lactam antibiotics at the 2001-2010 periods expressed as the number of DDD/100BD 
 
The most widely used, within the 10-year period of 
investigation, was ceftriaxone. Its maximum consumption was 
reported in 2007 (14.4 DDD/100BD). The secondly used was 
ciprofloxacin. Maximum consumption was registered in 2008 
(8.5 DDD/100BD). The use of the first-and second-generation 
cephalosporins increased throughout the years. The use of 
carbapenem also increased, which reached its maximum 
consumption in 2007 (3.0 DDD/100BD). It was the case with 
glycopeptides as well, which were maximally consumed in 2007 
(1.8 DDD/100BD) (fig. 2, table 2). 
 
Table 2: The consumption of particular antibiotics and groups of antibiotic drugs at the MMA between 2001 and 2010 expressed as the 
number of DDD/100BD 
Year 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 
Piperacillin- 
Tazobactam 
0.2 0.0 0.2 0.2 0.6 0.4 0.8 0.5 0.4 0.6 
Cefazolin 0.0 0.0 0.3 2.7 2.2 1.6 0.0 2.3 1.9 1.9 
Cefuroxime 0.0 0.0 0.0 0.6 1.5 1.2 1.7 3.7 6.0 3.9 
Ceftriaxone 13.9 14.0 13.4 8.0 9.0 9.2 14.4 5.9 7.4 12.7 
Imipenem- 
Cilastatin 
1.0 1.4 0.5 1.2 0.9 1.4 1.6 0.5 1.1 0.7 
Meropenem 0.0 0.0 0.0 0.2 0.5 0.9 1.2 2.0 1.4 1.7 
Amikacin 0.1 2.3 3.4 2.7 2.8 3.3 3.9 2.9 2.7 2.4 
Ciprofloxacin 2.5 4.7 6.0 2.3 3.9 6.5 6.6 8.5 6.8 7.3 
Vancomycin 0.2 0.3 0.1 0.7 1.3 0.6 1.3 0.7 1.3 1.1 
Teicoplanin 0.2 0.3 0.6 0.3 0.2 0.3 0.5 1.0 0.2 0.5 
Glycopeptides 0.4 0.6 0.7 1.0 1.5 0.9 1.8 1.7 1.5 1.6 
 
There are not many publications which used the numbers of 
DDD/100 BD as indicators, to express the antibiotic consumption. 
Published papers, only confirmed the correlation between the 
antibiotic consumption and increased antibiotic resistance, and vice 
versa. The increase of doses of particular antibiotic consumption 
leads to reduce its use, as modifying existing protocols. It is 
recommended to improve alternative protocols in such cases. [7]. 
During 2004 and 2005, the total antibiotic consumption, in 25 
hospitals, in the South and East Mediterranean, ranged from 45 to 
836 DDD/100BD [8], while, at the MMA, it reached the maximum of 
60.4 DDD/100BD over the 10-year period (table 1).  
The Medicines and Medical Devices Agency of Serbia published the 
data on the drug consumption throughout the years of 2004-2006. 
The highest rate of antibiotic consumption in hospitals was 
observed in 2005 (119.19 DDD/100BD) while the lowest rate of 
their use was reported in 2006 (57 DDD/100BD). The extended-
spectrum penicillins, along with aminoglycosides and 
cephalosporins of the third generation, were among the leading 
drugs used [9]. MMA in comparation with the other hospitals, in 
Serbia, use antibiotics much rationally. According to the European 
Surveillance of Antibiotic Consumption (ESAC), the penicillin 
consumption ranged from 17.9% in Finland to 56.9% in France; 
cephalosporins were the least frequently used in Ireland 8.4% and 
the most widely used in Bulgaria 44.5%, while the rate of quinolones 
use was from 6.9% in Norway to 21.8% in Hungary, in 2008. The 
rate of penicillin use at the MMA, in 2008 totaled 14.8%, while 
cephalosporins and quinolones, were used at the rates of 30.4% and 
15.3% respectively, in relation to the total antibiotic consumption 
[10]. The penicillins were less frequently used at the MMA, while 
cephalosporins and quinolones were used within the ranges 
reported from the European hospitals [10-12]. 
The most widely used antibiotic, in MMA, was ceftriaxone. The first 
significant drop in the consumption was observed in 2004 (8 
DDD/100BD), when the use was reduced by 42.1% in relation to the 
average consumption rate, in the last three years. The second 
significant drop, in the ceftriaxone consumption, occurred in 2008 
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(5.9 DDD/100BD), when its use decreased by 45.5% (table 2). These 
reductions in consumptions were the result of efforts of a 
multidisciplinary team in order to rationalize the use of antibiotics 
in MMA. However, over 2009 and 2010, its consumption started to 
rise, steadily again, because of the problems in supplying hospitals 
with antibiotics and other drugs. 
During the same period, a rise in the ciprofloxacin consumption has 
been noted (table 2). Increased quinolones consumption, may also 
be attributed to the healthcare-related diarrheas caused by 
Clostridium difficile (CDAD). The wide use of quinolones and 
cephalosporins was an important risk factor for epidemic CDAD in 
Denmark and Canada [13, 14]. In 2010, CDAD incidence rate at the 
MMA was 3.3 on 10.000 hospital days [15].  
A prospective cohort study of risk factors for SSI In 2006 in patients 
of MMA, demonstrated that SSIs were the most usually caused by 
Staphylococcus aureus (27.8%). The 64% isolates were methicillin-
resistant. Second causation was Enterococcus spp. (16.2%) without 
registered vancomycin resistance, along with Klebsiella spp. (13.9%) 
with 90% of the third-generation cephalosporins-resistant isolates 
[16]. Between 2006 and 2010 the SSI rate decreased from 6.3% to 
3.2% [17]. Furthermore, the use of carbapenems over 2006-2010 
period was stable (2.2-3 DDD/100BD). However, it was twice higher 
when compared to the period from 2001-2005. It was also 
concluded that the glycopeptides consumption was twice higher, in 
relation to the previous period in the last six years. (fig. 2, table 2). 
Nevertheless, consumption of carbapenems and glycopeptides, in 
particular, European hospitals and MMA in the early consumption 
period, was similar [10, 12]. It is important to stress out, that in 
2006 the Enterococcus spp isolated from SSIs was not resistant to 
vancomycin, while in 2010 was vancomycin-resistant in 25% of 
nosocomial infections (NI) registered in MMA [16, 18].  
The increase in consumption, of the third-generation cephalosporins, 
quinolones, carbapenems, and glycopeptides, may be correlated with the 
high rate of multi-resistance causative agents of NI registered within the 
framework of the Third National Prevalence Study of NI. More precisely, 
besides the increased Enterococcus spp. vancomycin bacterial resistance, 
it has been noted the Acinetobacter spp. resistance, to the third-
generation cephalosporins and carbapenems as well as the high 
resistance of bacteria Pseudomonas spp. on the third-generation 
cephalosporins (100%) and carbapenems (66.7%) [16, 18].  Within the 
10-year period the most widely used antibiotic, at the MMA, was 
ceftriaxone. There was a rise in the consumption of quinolones, 
carbapenems, and glycopeptides, which may be correlated to the 
high antimicrobial resistance of bacteria causative agents of NI in 
MMA. Analysis of antibiotic consumption and multidisciplinary 
approach has a crucial importance for further survey of protocols 
compliance, concerning the antibiotic consumption in one hospital. 
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